Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 11, 1999, Pages 965-970

  Woodson, Karen ^a,b   Stewart, Claudia ^c   Barrett, Mike ^d   Bhat, Narayan K ^c   Virtamo, Jarmo ^e   Taylor, Philip R ^b   Albanes, Demetrius ^b  

^a Cancer Prevention Studies Branch   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LONG TERM EXPOSURE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TOBACCO; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADULT; AGE DISTRIBUTION; AGED; ANTIOXIDANTS; BETA CAROTENE; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FINLAND; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMERASE CHAIN REACTION; RISK FACTORS; SAMPLING STUDIES; SMOKING; VITAMIN E;

EID: 0032699173     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Smith, C. A. D., Smith, G., and Wolf, C. R. Genetic polymorphisms in xenobiotic metabolism. Eur. J. Cancer, 30: 1935-1941, 1994.
2. Gonzalez, F. J., and Idle, J. R, Pharmacogenetic phenotyping and genotyping: present status and future potential. Clin. Pharmacokinet., 26: 59-70, 1994.
3. Ketterer, B., Harris, J. M., Talaska, G., Meyer, D. J., Pemble, S. E., Taylor, J. B., Lang, N. P., and Kadlubar, F. F. The human glutathione S-transferase supergene family, its polymorphism, and its effect on susceptibility to lung cancer. Environ. Health Perspect., 98: 87-94, 1992.
4. Seidegard, J., and Pero, R. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum. Genet., 69: 66-68, 1985.
5. Seidegard, J., Vorachek, W. R., Pero, R. W., and Pearson, W. R. Hereditary differences in the expression of the human glutathione transferase active on transtilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA, 85: 7293-7297, 1988.
6. Seidegard, J., Pero, R. W., Miller, D. G., and Beattie, E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis (Lond.), 7: 751-753, 1986.
7. Kihara, M., and Noda, K. Lung cancer risk of GSTMI null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis (Lond.), 15: 415-418, 1994.
8. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., and Vainio, H. The GSTMI null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis (Lond.), 14: 1479-1481, 1993.
9. Saarikoski, S. T., Voho, A., Reinikainen, M., Anttila, S., Karjalainen, A., Malaveille, C., Vainio, H., Husgafvel-Pursiainen, K., and Hirvonen, A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int. J. Cancer, 77: 516-521, 1998.
10. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility of lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993.
11. Zhong, S., Howie, A. F., Ketterer, B., Taylor, J., Hayes, J. D., and Beckett, G. J. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis (Lond.), 12: 1533-1537, 1991.
12. Brockmoller, J., Kerb, R., Drakoulis, N., Nitz, M, and Roots, I. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res., 53: 1004-1011, 1993.
13. Alexandrie, A. K., Sundberg, M., Seidegard, J., Tornling, G., and Rannug, A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis (Lond.), 15: 1785-1790, 1994.
14. London, S. J., Daly, A. K., Cooper, J., Navidi, W. C., Carpenter, C. L., and Idle, J. R. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J. Natl. Cancer Inst., 16: 1246-1253, 1995.
15. ATBC Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann. Epidemiol., 44: 1-10, 1994.
16. Albanes, D., Heinonen, O. P., Taylor, P. R., Virtamo, J., Edwards, B. K., Rautalahti, M., Hartman, A. M., Palmgren, J., Freedman, L. S., Haapakoski, J., Barrett, M. J., Pietinen, P., Malila, N., Tala, E., Liippo, K., Salomaa, E-R., Tangrea, J. A., Teppo, L., Askin, F. B., Taskinen, E., Erozan, Y., Greenwald, P., and Huttunen, J. K. α-Tocopherol, and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst., 88: 1560-1570, 1996.
17. ATBC Cancer Prevention Study Group. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med., 330: 1029-1035, 1994.
18. Woodson, K., Ratnasinghe, D., Albanes, D., Bhat, N. K., Stewart, C., Tangrea, J. A., Hartman, T. J., Stolzenberg-Solomon, R., Virtamo, J., Taylor, P. R., and Albanes, D. Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial. Eur. J. Cancer Prev., 8: 255-260, 1999.
19. McWilliams, J. E., Sanderson, B. J., Harris, E. L., Richert-Boe, K. E., and Henner, W. D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 4: 589-594, 1995.
20. Kato, S., Bowman, E. D., Harrington, A. M., Blomeke, B., and Shields, P. G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst., 87: 902-907, 1995.
21. Liu, Y. H., Taylor, J., Linko, P., Lucier, G. W., and Thompson, C. L. Glutathione S-transferase mu in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis (Lond.), 12: 2269-2275, 1991.
22. Wiencke, J. K., Kelsey K. T., Lamela, R. A., and Toscano, W. A. J. Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res., 50: 1585-1590, 1990.
23. van Poppel, G., de Vogel, N., van Balderen, P., and Kok, F. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu. Carcinogenesis (Lond.), 13: 303-305, 1992.
24. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993.
25. Kihara, M., and Noda, K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis (Lond.), 16: 2331-2336, 1995.
26. Mooney, L. A., Bell, D., Santella, R. M., van Bennekum, A. M., Ottman, R., Paik, M., Blaner, W. S., Lucier, G. W., Covey, L., Young, T. L., Cooper, T. B., Glassman, A. H., and Perera, F. P. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis (Lond.), 18: 503-509, 1997.
27. Grinberg-Funes, R. A., Singh, V., Perera, F., Bell, D., Young, T., Dickey, C., Wang, L., and Santella, R. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione S-transferase M1 genotype. Carcinogenesis (Lond.), 15: 2449-2454, 1994.
28. Seidegard, J., and Ekstrom, G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ. Health Perspect., 105S: 791-799, 1997.
29. van Lieshout, E. M., Peters, W. H. M., and Jansen, J. Effect of oltipraz, α-tocopherol. β-carotene and phenethylisothiocyanate on rat oesophageal, gastric, colonic and hepatic glutathione, glutathione S-transferase and peroxidase. Carcinogenesis (Lond.), 17: 1439-1445, 1996.
30. Chen, L. H., and Shiau, C-C. A. Induction of glutathione S-transferase activity by antioxidants in hepatocyte culture. Anticancer Res., 9: 1069-1072, 1989.
31. Duthie, S. J., Ma, A., Ross, M. A., and Collins, A. R. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res., 56: 1291-1295, 1996.
32. Sigounas, G., Anagnostou, A., and Steiner, M. DL-α-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr. Cancer, 28: 30-35, 1997.
33. Meydani, S. N., and Beharka, A. A. Recent developments in vitamin E and immune response. Nutr. Rev., 56: S49-S58, 1998.
34. Paolini, M., Cantelli-Forti, G., Perocco, P., Pedulli, G. F., Abdel-Rahman, S. Z., and Legator, M. S. Co-carcinogenic effect of β-carotene. Nature (Lond.), 398: 760-761, 1999.